Travel and sexually transmitted infections

Journal of Travel Medicine

Volumn 13, Issue 5, 2006, Pages 300-317

  Ward, Brian J ^a   Plourde, Pierre ^b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b WINNIPEG REGIONAL HEALTH AUTHORITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; EFAVIRENZ; ERYTHROMYCIN; FAMCICLOVIR; GENTAMICIN; HEPATITIS B VACCINE; IMIQUIMOD; KANAMYCIN; LAMIVUDINE PLUS ZIDOVUDINE; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; PODOPHYLLOTOXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG; VALACICLOVIR; ZIDOVUDINE;

ALCOHOL CONSUMPTION; ANTIBIOTIC RESISTANCE; ARMY; CONDOM; DEVELOPED COUNTRY; DEVELOPING COUNTRY; HEALTH PROMOTION; HIGH RISK POPULATION; HISTORY; HOMOSEXUALITY; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFECTION RISK; PEDIATRICS; PERSONAL EXPERIENCE; POPULATION MIGRATION; PREGNANCY; PREVALENCE; PUBLIC HEALTH; REVIEW; SAILOR; SEXUAL BEHAVIOR; SEXUAL CRIME; SEXUAL HEALTH; SEXUALLY TRANSMITTED DISEASE; SOCIAL ISOLATION; SUBSTANCE ABUSE; TOURISM; TRAVEL;

DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MALE; RAPE; RISK REDUCTION BEHAVIOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; TRAVEL; WORLD HEALTH;

EID: 33748920909     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2006.00061.x     Document Type: Review

References (179)

1. Zimmerman C. Violence against women: global scope and magnitude. Lancet 2002; 359:1232-1237.
2. Rogers S. Rolling down to old Maui. Available at:http://www.ifred.ca/ stanrogers/songs.html. (Accessed 2006 Aug 16)
3. Watt J. Lettsomian lectures. Medical perspectives of some voyages of discovery. Trans Roy Soc Lond 1979; 95:61-91.
4. World Tourism Organization. Tourism highlight 2003. Available at: http://www.world-tourism.org/market_research/facts/menu.html. (Accessed 2006 Aug 21)
5. Mulhall BP. Sex and travel: studies of sexual behaviour, disease and health promotion in international travelers - a global review. Int J STD AIDS 1996; 7:455-465.
6. Aral SO. Sexually transmitted diseases: magnitude, determinants and consequences. Int J STD AIDS 2001; 12:211-215.
7. Aral SO. Determinants of STI epidemics: implications for phase appropriate intervention strategies. Sex Transm Infect 2002; 78(Suppl 1):3-13.
8. Abdullah AS, Ebrahim SH, Fielding R, Morisky DE. Sexually transmitted infections in travelers: implications for prevention and control. Clin Infect Dis 2004; 39:533-538.
9. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: WHO. WHO/CDS/CSR/EDC/2001.10. 2001; 1-54.
10. Ruiz J. Street youth in Colombia: lifestyle, attitudes and knowledge. AIDS Health Promot Exch 1994; 1:12-14.
11. Msuya W, Mayaud P, Mkanje R, Grosskurth H. Taking early action in emergencies to reduce the spread of STIs and HIV. Afr Health 1996; 18:24.
12. van den Hoek A. STI control in drug users and street youth. Genitourin Med 1997; 73:240-244.
13. Rew L. Sexual health practices of homeless youth: a model for intervention. Issues Compr Pediatr Nurs 2001; 24:1-18.
14. Roy E, Haley N, Leclerc P, et al. Mortality in a cohort of street youth in Montreal. JAMA 2004; 292:569-574.
15. World Health Organization. WHO. Office of Information. Sexually transmitted infections ncreasing - 250 million new infections annually. WHO Feature 1990; 152:1-6.
16. Gerbase AC, Rowley JT, Heymann DH, et al. Global prevalence and incidence estimates of selected curable STIs. Sex Transm Infect 1998; 74(Suppl 1):S12-S16.
17. Gerbase AC, Rowley JT, Mertens TE. Global epidemiology of sexually transmitted diseases. Lancet 1998; 351:2-4.
18. Shetty AK, Powell G. Children orphaned by AIDS: a global perspective. Semin Pediatr Infect Dis 2003; 14:25-31.
19. Foster, G. Africa's children and AIDS-a continent in crisis. The devastators of the HIV/AIDS pandemic. AIDS link 1997 May-June; 4-5.
20. Anonymous. Street children turn to sex-work to survive. AIDS Anal Afr 1995; 5:6-7.
21. Brunham RC, Plummer FA. A general model of sexually transmitted disease epidemiology and its implications for control. Med Clin North Am 1990; 74:1339-1352.
22. Saphonn V, Hor LB, Ly SP, et al. How well do antenatal clinic (ANC) attendees represent the general population? A comparison of HIV prevalence from ANC sentinel surveillance sites with a population-based survey of women aged 15-49 in Cambodia. Int J Epidemiol 2002; 31:449-455.
23. Aboyeji AP, Nwabuisi C. Prevalence of sexually transmitted diseases among pregnant women in Ilorin, Nigeria. J Obstet Gynaecol 2003; 23:637-639.
24. Latif AS, Bvumbe J, Muongerwa J, et al. Sexually transmitted diseases in pregnant women in Harare, Zimbabwe. Afr J Sex Transmi Dis 1984; 1:21-23.
25. Duncan ME, Tibaux G, Kloos H, et al. STIS in women attending family planning clinics: a case study in Addis Ababa. Soc Sci Med 1997; 44:441-454.
26. Pham-Kanter GB, Steinberg MH, Ballard RC. Sexually transmitted diseases in South Africa. Genitourin Med 1996; 72:160-171.
27. Blankhart D, Muller O, Gresenguet G, Weis P. Sexually transmitted infections in young pregnant women in Bangui, Central African Republic. Int J STD AIDS 1999; 10:609-614.
28. Kilmarx PH, Black CM, Limpakarnjanarat K, et al. Rapid assessment of sexually transmitted diseases in a sentinel population in Thailand: prevalence of chlamydial infection, gonorrhoea, and syphilis among pregnant women - 1996. Transm Infect 1998; 74:189-193.
29. Thomas K, Thyagarajan SP, Jeyaseelan L, et al. Community prevalence of sexually transmitted diseases and human immunodeficiency virus infection in Tamil Nadu, India: a probability proportional to size cluster survey. Natl Med J India 2002; 15:135-140.
30. Purevdawa E, Moon TD, Baigalmaa C, et al. Rise in sexually transmitted diseases during democratization and economic crisis in Mongolia. Int J STD AIDS 1997; 8:398-401.
31. Cowan FM, French RS, Mayaud P, et al. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm Infect 2003; 79:286-290.
32. Parenti DM. Sexually transmissible diseases and travelers. Med Clin North Am 1992; 76:1449-1461.
33. Wang CC, Celum CL. Global risk of sexually transmitted diseases. Med Clin North Am 1999; 83:975-995.
34. Ndoye I, Mboup S, De Schryver A, et al. Diagnosis of sexually transmitted infections in female prostitutes in Dakar, Senegal. Sex Transm Infect 1998; 74(Suppl 1):S112-S117.
35. Ramjee G, Karim SS, Sturm AW. Sexually transmitted infections among sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis 1998; 25:346-349.
36. van den Hoek A, Yuliang F, Dukers NH, et al. High prevalence of syphilis and other sexually transmitted diseases among sex workers in China: potential for fast spread of HIV. AIDS 2001; 15:753-759.
37. Sugihantono A, Slidell M, Syaifudin A, et al. Syphilis and HIV prevalence among commercial sex workers in Central Java, Indonesia: risk-taking behavior and attitudes that may potentiate a wider epidemic. AIDS Patient Care STDS 2003; 17:595-600.
38. Ford K, Wirawan DN, Reed BD, et al. AIDS and STI knowledge, condom use and HIV/STI infection among female sex workers in Bali, Indonesia. AIDS Care 2000; 12:523-534.
39. Joesoef MR, Linnan M, Barakbah Y, et al. Patterns of sexually transmitted diseases in female sex workers in Surabaya, Indonesia. Int J STD AIDS 1997; 8:576-580.
40. Sarkar S, Islam N, Durandin F, et al. Low HIV and high STI among commercial sex workers in a brothel in Bangladesh: scope for prevention of larger epidemic. Int J STD AIDS 1998; 9:45-47.
41. Joesoef MR, Gultom M, Irana ID, et al. High rates of sexually transmitted diseases among male transvestites in Jakarta, Indonesia. Int J STD AIDS 2003; 14:609-613.
42. Camejo MI, Mata G, Diaz M. Prevalence of hepatitis B, hepatitis C and syphilis in female sex workers in Venezuela. Rev Saude Publica 2003; 37:339-344.
43. Mesquita PE, Granato CF, Castelo A. Risk factors associated with hepatitis C virus (HCV) infection among prostitutes and their clients in the city of Santos, Sao Paulo State, Brazil. J Med Virol 1997; 51:338-343.
44. Hyams KC, Phillips IA, Tejada A, et al. Three-year incidence study of retroviral and viral hepatitis transmission in a Peruvian prostitute population. J Acquir Immune Defic Syndr 1993; 6:1353-1357.
45. Russi JC, Serra M, Vinoles J, et al. Sexual transmission of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 infections among male transvestite comercial sex workers in Montevideo, Uruguay. Am J Trop Med Hyg 2003; 68:716-720.
46. Laurent C, Henzel D, Mulanga-Kabeya C, et al. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. Int J Epidemiol 2001; 30:872-877.
47. Pando MA, Berini C, Bibini M, et al. Prevalence of HIV and other sexually-transmitted infections among female commercial sex workers in Argentina. Am J Trop Med Hyg 2006; 74:233-238.
48. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11:97-107.
49. Ray Kim W. Global epidemiology and burden of hepatitis C. Microbes Infect 2002; 4:1219-1225.
50. The Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004; 44:20-29.
51. Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 2000; 18:109-119.
52. Erbelding E, Quinn TC. The impact of antimicrobial resistance on the treatment of sexually transmitted diseases. Infect Dis Clin North Am 1997; 11:889-903.
53. CDC. Global distribution of penicillinase-producing Neisseria gonorrhoeae (PPNG). MMWR Morb Mortal Wkly Rep 1982; 31:1-3.
54. Brown S, Warnnissorn T, Biddle J, et al. Antimicrobial resistance of Neisseria gonorrhoea in Bangkok: is single-drug treatment passe. Lancet 1982; 2:1366-1368.
55. Bodonaik NC. Decrease in the incidence of tetracycline resistance in strains of Neisseria gonorrhoeae in the nineties. West Indian Med J 2003; 52:228-230.
56. Bogaerts J, Van Dyck E, Mukantabana B, et al. Auxotypes, serovars, and trends of antimicrobial resistance of Neisseria gonorrhoeae in Kigali, Rwanda (1985-93). Sex Transm Infect 1998; 74:205-209.
57. Ison CA, Dillon JA, Tapsall JW. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi. Lancet 1998; 351(Suppl 3):8-11.
58. De Schryver A, Meheus A. International travel and sexually transmitted diseases. World Health Stat Q 1989; 42:90-99.
59. De Schryver A, Meheus A. Epidemiology of sexually transmitted diseases: the global picture. Bull World Health Organ 1990; 68:639-654.
60. Yeung KH, Dillon JA. Cases of Neisseria gonorrhoeae with plasmid-mediated resistance to penicillin increase. The National Study Group. Can Dis Wkly Rep 1990; 16:13-16.
61. Ng LK, Martin I, Lau A; The National Gonococcal Surveillance Program Members. Trends of chromosomally mediated antimicrobial resistance in Neisseria gonorrhoeae in Canada: 1994-1999. Sex Transm Dis 2003; 30:896-900.
62. Sarwal S, Wong T, Sevigny C, Ng LK. Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada. CMAJ 2003; 168:872-873.
63. Patrick D, Shaw C, Rekart ML. Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in British Columbia: an imported phenomenon. Can Commun Dis Rep 1995; 21:137-139.
64. Ehret JM, Judson FN. Quinolone-resistant Neisseria gonorrhoeae: the beginning of the end? Report of quinolone-resistant isolates and surveillance in the southwestern United States, 1989 to 1997. Sex Transm Dis 1998; 25:522-526.
65. Herida M, Sednaoui P, Goulet V. Gonorrhoea surveillance system in France: 1986-2000. Sex Transm Dis 2004; 31:209-214.
66. Carballo M, Pauze M, Dillon JR. Increase of Neisseria gonorrhoeae isolates with combined plasmid-mediated resistance to tetracycline (TRNG) and penicillin (PPNG). Can Dis Wkly Rep 1990; 16:219-222.
67. Rousseau D, Nadeau D, Lafontaine G. Emergence of spectinomycin-resistant strains of penicillinase-producing Neisseria gonorrhoeae (PPNG) - Quebec. Can Dis Wkly Rep 1989; 15:101-102; discussion 102-103.
68. Ray K, Bala M, Kumari S, Narain JP. Antimicrobial resistance of Neisseria gonorrhoeae in selected World Health Organization Southeast Asia Region countries: an overview. Sex Transm Dis 2005; 32:178-184.
69. Mann J, Kropp R, Wong T, Venne S, Romanowski B. Gonorrhea treatment guidelines in Canada: 2004 update. CMAJ 2004; 171:1345-1346.
70. Rutanarugsa A, Vorachit M, Polnikorn N, Jayanetra P. Drug resistance of Haemophilus ducreyi. Southeast Asian J Trop Med Public Health 1990; 21:185-193.
71. Harries AD, Nyangulu DS, Hargreaves NJ, et al. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001; 358:410-414.
72. Blower S, Ma L, Farmer P, Koenig S. Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance. Curr Drug Targets Infect Disord 2003; 3:345-353.
73. Nkengasong JN, Adje-Toure C, Weidle PJ. HIV antiretroviral drug resistance in Africa. AIDS Rev 2004; 6:4-12.
74. Steffen R, deBernardis C, Banos A. Travel epidemiology - a global perspective. Int J Antimicrob Agents 2003; 21:89-95.
75. Rowbottom J. STIs and the overseas traveller. Aust Fam Physician 1993; 22:125-131.
76. Mulhall BP, Hu M, Thompson M, et al. Planned sexual behaviour of young Australian visitors to Thailand. Med J Aust 1993; 158:530-535.
77. Bloor M, Thomas M, Hood K, et al. Differences in sexual risk behaviour between young men and women travelling abroad from the UK. Lancet 1998; 352:1664-1668.
78. Hawkes S, Hart G. The sexual health of travelers. Infect Dis Clin North Am 1998; 12:413-430.
79. Forsythe S. HIV/AIDS and tourism. AIDS Anal Afr 1999; 9:4-6.
80. Fenton KA, Chinouya M, Davidson O, Copas A, MAYISHA research team. HIV transmission risk among sub-Saharan Africans in London travelling to their countries of origin. AIDS 2001; 15:1442-1445.
81. Matteelli A, Carosi G. Sexually transmitted diseases in travelers. Clin Infect Dis 2001; 32:1063-1067.
82. Correia JD, Shafer RT, Patel V, et al. Blood and body fluid exposure as a health risk for international travelers. J Travel Med 2001; 8:263-266.
83. Bellis MA, Hughes K, Thomson R, Bennett A. Sexual behaviour of young people in international tourist resorts. Sex Transm Infect 2004; 80:43-47.
84. Hynes NA. Sexually transmitted diseases in travelers. Curr Infect Dis Rep 2005; 7:132-137.
85. Steffen R, Rickenbach M, Wilhelm U, et al. Health problems after travel to developing countries. J Infect Dis 1987; 156:84-91.
86. Finney H. Contraceptive use by medical students whilst on holiday. Fam Pract 2003; 20:93.
87. Arvidson M, Hellberg D, Mardh PA. Sexual risk behavior and history of sexually transmitted diseases in relation to casual travel sex during different types of journeys. Acta Obstet Gynecol Scand 1996; 75:490-494.
88. Cabada MM, Echevarria JI, Seas CR, et al. Sexual behavior of international travelers visiting Peru. Sex Transm Dis 2002; 29:510-513.
89. Cabada MM, Montoya M, Echevarria JI, et al. Sexual behavior in travelers visiting Cuzco. J Travel Med 2003; 10:214-218.
90. Batalla-Duran E, Oakeshott P, Hay P. Sun, sea and sex? Sexual behaviour of people on holiday in Tenerife. Fam Pract 2003; 20:493-494.
91. Gagneux OP, Blochliger CU, Tanner M, Hatz CF. Malaria and casual sex: what travelers know and how they behave. J Travel Med 1996; 3:14-21.
92. de Graaf R, van Zessen G, Houweling H. Underlying reasons for sexual conduct and condom use among expatriates posted in AIDS endemic areas. AIDS Care 1998; 10:651-665.
93. Bonneaux L, Van der Stuyft P, Taelman H, et al. Risk factors for infection with human immunodeficiency virus among European expatriates in Africa. BMJ 1988; 297:581-584.
94. Jones ME. HIV and the returning expatriate. J Travel Med 1999; 6:99-106.
95. Herold ES, Van Kerkwijk C. AIDS and sex tourism. AIDS Soc 1992; 4:1, 8.
96. Stricker M, Steffen R, Hornung R, et al. Flûchtige sexuelle Kontakte von Scheizer Touristen in den Tropen. Mûnch Med Wschr 1990; 132:175-177.
97. Tveit KS, Nilsen A, Nyfors A. Casual sexual experience abroad in patients attending an STI clinic and at high risk for HIV infection. Genitourin Med 1994; 70:12-14.
98. Gillies P, Slack R, Stoddart N, Conway S. HIV-related risk behaviour in UK holiday-makers. AIDS 1992; 6:339-341.
99. Bryant KJ. Decreasing HIV/STI risk in relation to alcohol use: a research agenda. AIDS STD Health Promot Exch 1997; 2:13-15.
100. Fortenberry JD. Alcohol, drugs, and STI/HIV risk among adolescents. AIDS Patient Care STDS 1998; 12:783-786.
101. Gehring TM, Widmer J, Kleiber D, Steffen R. Are preventive HIV interventions at airports effective? J Travel Med 1998; 5:205-209.
102. Minichiello V, Marino R, Khan MA, Browne J. Alcohol and drug use in Australian male sex workers: its relationship to the safety outcome of the sex encounter. AIDS Care 2003; 15:549-561.
103. Apostolopoulos Y, Sonmez S, Yu CH. HIV-risk behaviours of American spring break vacationers: a case of situational disinhibition? Int J STD AIDS 2002; 13:733-743.
104. Mewhinney DM, Herold ES, Maticka-Tyndale E. Sexual scripts and risk taking of Canadian university students on spring break in Daytona beach, Florida. Can J Hum Sex 1995; 3:273-288.
105. Moore J, Beeker C, Harrison JS, et al. HIV risk behavior among Peace Corps Volunteers. AIDS 1995; 9:795-799.
106. Houweling H, Coutinho RA. Risk of HIV infection among Dutch expatriates in sub-Saharan Africa. Int J STD AIDS 1991; 2:252-257.
107. de Graaf R, van Zessen G, Houweling H, et al. Sexual risk of HIV infection among expatriates posted in AIDS endemic areas. AIDS 1997; 11:1173-1181.
108. Bacaner N, Stauffer B, Boulware DR, et al. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA 2004; 291:2856-2864.
109. Fulford M, Keystone JS. Health risks associated with visiting friends and relatives in developing countries. Curr Infect Dis Rep 2005; 7:48-53.
110. Wallace D. WESTPAC, AIDS, and the Navy. Mil Med 1994; 159:171-173.
111. Anonymous. High condom quality essential to reduce HIV spread. Network 1988; 10:6-7.
112. Kramer MA, van den Hoek A, Coutinho RA, Prins M. Sexual risk behaviour among Surinamese and Antillean migrants travelling to their countries of origin. Sex Transm Infect 2005; 81:508-510.
113. Adams EJ, Strike PW, Green AD, Masterton RG. Sexually transmitted diseases in transient British forces in the tropics. Genitourin Med 1994; 70:94-96.
114. Shafer MA, Boyer CB, Shaffer RA, et al. Correlates of sexually transmitted diseases in a young male deployed military population. Mil Med 2002; 167:496-500.
115. Hopperus Buma AP, Veltink RL, van Ameijden EJ, et al. Sexual behaviour and sexually transmitted diseases in Dutch marines and naval personnel on a United Nations mission in Cambodia. Genitourin Med 1995; 71:172-175.
116. Miller N, Yeager R. By virtue of their occupation, soldiers and sailors are at greater risk. Special report: the military. AIDS Anal Afr 1995; 5:8-9.
117. Vuksanovic P, Goethe WH, Burchard HV, et al. Seamen and AIDS. Travel Med Int 1988; 6:18-19.
118. Pavli P, Bayliss GJ, Dent OF, Lunzer MR. The prevalence of serological markers for hepatitis B virus infection in Australian Naval personnel. Med J Aust 1989; 151:71, 74-75.
119. Tiwari VD, Talwar S, Panvelkar VV, Tutakne MA. Wars and sexually transmitted diseases in the Indian Army. Indian J Sex Transm Dis 1992; 13:80-82.
120. Bond MM, Yates SW. Sexually transmitted disease screening and reporting practices in a military medical center. Mil Med 2000; 165:470-472.
121. Malone JD, Hyams KC, Hawkins RE, et al. Risk factors for sexually-transmitted diseases among deployed U.S. military personnel. Sex Transm Dis 1993; 20:294-298.
122. Abel E, Adams E, Stevenson R. Sexual risk behaviour among female army recruits. Mil Med 1996; 161:491-494.
123. Hawkes S, Hart GJ, Bletsoe E, et al. Risk behaviour and STI acquisition in genitourinary clinic attenders who have travelled. Genitourin Med 1995; 71:351-354.
124. Clift SM, Forrest SP. Factors associated with gay men's sexual behaviours and risk on holiday. AIDS Care 1999; 11:281-295.
125. Salit IE, Sano M, Boggild AK, Kain KC. Travel patterns and risk behaviour of HIV-positive people travelling internationally. CMAJ 2005; 172:884-888.
126. Fenton KA, Imrie J. Increasing rates of sexually transmitted diseases in homosexual men in Western Europe and the United States: why? Infect Dis Clin North Am 2005; 19:311-331.
127. Hawkes S, Hart GJ, Johnson AM, et al. Risk behaviour and HIV prevalence in international travellers. AIDS 1994; 8:247-252.
128. Thorpe L, Ford K, Fajans P, Wirawan DN. Correlates of condom use among female prostitutes and tourist clients in Bali, Indonesia. AIDS Care 1997; 9:181-197.
129. Abdullah AS, Fielding R, Hedley AJ, Luk YK. Risk factors for sexually transmitted diseases and casual sex among Chinese patients attending sexually transmitted disease clinics in Hong Kong. Sex Transm Dis 2002; 29:360-365.
130. Kleiber D, Wilke M. Sexual behaviour of German (sex) tourists. Abstract WS-D110-2, 9th International Conference on AIDS, Berlin, Germany 1993.
131. Songkhla MN. Quality control of condoms in Thailand: a case study. J Med Assoc Thai 1993; 76:353-358.
132. Deparis X, Migliani R, Merlin M. Evidence of risk factors for condom breakage among French military personnel stationed overseas. Med Trop (Mars) 1999; 59:266-270.
133. Brisson M, Boily MC, Masse BR, et al. Highlights of the sexual activity of the heterosexual population in the province of Quebec. Sex Transm Infect 1999; 75:296-299.
134. Leder K, Weller PF, Wilson ME. Travel vaccines and elderly persons: review of vaccines available in the United States. Clin Infect Dis 2001; 33:1553-1566.
135. Wilson MM. Sexually transmitted diseases. Clin Geriatr Med 2003; 19:637-655.
136. Van Kerkwijk C. Sex tourism in Thailand. AIDS Soc 1992; 4:6-7.
137. Marrazzo JM. Sexual tourism: implications for travelers and the destination culture. Infect Dis Clin North Am 2005; 19:103-120.
138. Puro V, De Carli G, Scognamiglio P, et al. Risk of HIV and other blood-borne infections in the cardiac setting: patient-to-provider and provider-to-patient transmission. Ann N Y Acad Sci 2001; 946:291-309.
139. Pinkerton SD, Martin JN, Roland ME, et al. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus. Arch Intern Med 2004; 164:46-54.
140. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002; 36(5 Suppl 1):S99-S105.
141. O'Farrell N. Transmission of HIV: genital ulceration, sexual behaviour, and circumcision. Lancet 1989; 2:1157.
142. Robinson WS. Hepatitis B virus and hepatitis D virus. In: Mandel G, Bennet JE, Dolin R, eds. Principles and practice of infectious diseases. Philadelphia, Churchill Livingstone, 2000:1652-1684.
143. Sparling PF, Handsfield HH. Neisseria gonorrheae. In: Mandel G, Bennet JE, Dolin R, eds. Principles and practice of infectious diseases. Philadelphia, Churchill Livingstone, 2000:2242-2258.
144. Warner L, Newman DR., Austin HD, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol 2004; 159:242-251.
145. Larouze B, Gaudebout C, Mercier E, et al. Infection with hepatitis A and B viruses in French volunteers working in tropical Africa. Am J Epidemiol 1987; 126:31-37.
146. Lange WR, Frame JD. High incidence of viral hepatitis among American missionaries in Africa. Am J Trop Med Hyg 1990; 43:527-533.
147. Arvidson M, Hellberg D, Mardh PA. Sexually transmitted diseases in Swedish women with experience of casual sex with men of foreign nationalities within Sweden. Acta Obstet Gynecol Scand 1995; 74:794-798.
148. Hiltunen-Back E, Haikala O, Koskela P, et al. Epidemics due to imported syphilis in Finland. Sex Transm Dis 2002; 29:746-751.
149. Abdullah AS, Fielding R, Hedley AJ, et al. Related reasons for not using condoms among the Hong Kong Chinese population: implications for HIV and STD prevention. Sex Transm Infect 2002; 78:180-184.
150. Gunn RA, Harper SL, Borntrager DE, et al. Implementing a syphilis elimination and importation control strategy in a low-incidence urban area: San Diego County, California, 1997-1998. Am J Public Health 2000; 90:1540-1544.
151. Public Health Agency of Canada. Canadian guidelines on sexually transmitted infections 2006 (in press) Available at: http://www.phac-aspc.gc.ca/ stdmts/sti_2006/sti-intro2006-e.html (2006 Aug 21).
152. CDC. Update: barrier protection against HIV infection and other sexually transmitted diseases. MMWR 1993; 42:589-591, 597.
153. Donovan B. Sexually transmissible infections other than HIV. Lancet 2004; 363:545-556.
154. Gallo MF, Grimes DA, Schulz KF. Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev 2003; 2:CD003550.
155. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82:454-461.
156. Latka M. Female-initiated barrier methods for the prevention of STI/HIV: where are we now? Where should we go? J Urban Health 2001; 78:571-580.
157. Macaluso M, Lawson ML, Hortin G, et al. Efficacy of the female condom as a barrier to semen during intercourse. Am J Epidemiol 2003; 157:289-297.
158. Rosenberg M. Contraception and STIs. IPPF Med Bull 1991; 25:3-4.
159. Wilkinson D, Ramjee G, Tholandi M, Rutherford G. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. Cochrane Database Syst Rev 2002; 4:CD003939.
160. Wilkinson D, Tholandi M, Ramjee G, Rutherford GW. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women. Lancet Infect Dis 2002; 2:613-617.
161. Kemper C. Consider postexposure STI screening. AIDS Alert 2002; 17:22.
162. Various authors. Canadian STI best practice guidelines. Can J Infect Dis Med Microbiol 2005; 16: Numbers 1 (1-55) and
163. Can J Infect Dis Med Microbiol 2 (1-98).
164. Basuki E, Wolffers I, Deville W, et al. Reasons for not using condoms among female sex workers in Indonesia. AIDS Educ Prev 2002; 14:102-116.
165. McKinzie J. Sexually transmitted diseases. Emerg Med Clin North Am 2001; 19:723-743.
166. Cantu M, Coppola M, Lindner AJ. Evaluation and management of the sexually assaulted woman. Emerg Med Clin North Am 2003; 21:737-750.
167. Dallabetta G. HIV and STDS: how are they linked? Afr Health 1994; 17:19-20.
168. Conard LA, Gold MA. Emergency contraceptive pills: a review of the recent literature. Curr Opin Obstet Gynecol 2004; 16:389-395.
169. Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004; 4:456-466.
170. Kamenga MC, De Cock KM, St Louis ME, et al. The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case-control study in Abidjan, Ivory Coast. Am J Obstet Gynecol 1995; 172:919-925.
171. Bukusi EA, Cohen CR, Stevens CE, et al. Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy. Am J Obstet Gynecol 1999; 181:1374-1381.
172. Smith KJ, Skelton H. Molluscum contagiosum: recent advances in pathogenic mechanisms, and new therapies. Am J Clin Dermatol 2002; 3:535-545.
173. Khan SA. Compulsory screening of immigrants for TB and HIV: broader focus is needed for immigration and health issues. BMJ 2004; 328:897.
174. Klein A. Canadian news. Concerns raised about new immigration rules. Can HIV AIDS Policy Law Rev 2002; 6:32-33.
175. Calvet HM. Sexually transmitted diseases other than human immunodeficiency virus infection in older adults. Clin Infect Dis 2003; 36:609-614.
176. Sanford C. Pre-travel advice: an overview. Prim Care 2002; 29:767-785.
177. De Serres G, Duval B, Shadmani R, et al. Ineffectiveness of the current strategy to prevent hepatitis A in travelers. J Travel Med 2002; 9:10-16.
178. Fletcher MA. Vaccine candidates in STD. Int J STD AIDS 2001; 12:419-422.
179. MacPherson DW. Evidence-based medicine. CMAJ 1995; 152:201-204.